(Q33962223)
Statements
Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy (English)
D McMahon
J Jones
A Wiegand
S Palmer
S McNulty
J A Metcalf
E Acosta
C Rehm
J M Coffin
J W Mellors